CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 86 filers reported holding CHEMOCENTRYX INC in Q4 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,432,000 | +13.3% | 279,381 | -45.7% | 0.00% | 0.0% |
| Q2 2022 | $12,740,000 | -18.4% | 514,124 | -17.5% | 0.00% | -25.0% |
| Q1 2022 | $15,617,000 | -61.9% | 622,930 | -44.7% | 0.00% | -50.0% |
| Q4 2021 | $41,017,000 | +37.0% | 1,126,512 | -35.6% | 0.01% | +33.3% |
| Q3 2021 | $29,935,000 | +92.0% | 1,750,587 | +50.4% | 0.01% | +50.0% |
| Q2 2021 | $15,590,000 | -22.2% | 1,164,239 | +197.8% | 0.00% | 0.0% |
| Q1 2021 | $20,034,000 | -48.6% | 390,980 | -37.9% | 0.00% | -60.0% |
| Q4 2020 | $39,014,000 | +32.1% | 630,071 | +16.9% | 0.01% | +25.0% |
| Q3 2020 | $29,528,000 | -39.2% | 538,825 | -36.1% | 0.01% | -52.9% |
| Q2 2020 | $48,537,000 | +50.4% | 843,538 | +5.0% | 0.02% | +13.3% |
| Q1 2020 | $32,265,000 | +384.6% | 803,025 | +377.0% | 0.02% | +400.0% |
| Q4 2019 | $6,658,000 | +841.7% | 168,351 | +61.4% | 0.00% | – |
| Q3 2019 | $707,000 | +113.6% | 104,316 | +193.0% | 0.00% | – |
| Q2 2019 | $331,000 | -71.2% | 35,600 | -56.9% | 0.00% | – |
| Q1 2019 | $1,148,000 | +129.6% | 82,633 | +80.1% | 0.00% | – |
| Q4 2018 | $500,000 | -43.2% | 45,873 | -34.1% | 0.00% | – |
| Q3 2018 | $880,000 | -30.9% | 69,601 | -28.0% | 0.00% | -100.0% |
| Q2 2018 | $1,273,000 | +203.8% | 96,627 | +213.4% | 0.00% | – |
| Q1 2018 | $419,000 | -28.0% | 30,829 | -68.5% | 0.00% | – |
| Q4 2017 | $582,000 | +7.2% | 97,923 | +33.8% | 0.00% | – |
| Q3 2017 | $543,000 | +364.1% | 73,179 | +485.1% | 0.00% | – |
| Q2 2017 | $117,000 | -33.1% | 12,508 | -48.1% | 0.00% | – |
| Q1 2017 | $175,000 | -43.0% | 24,088 | -41.9% | 0.00% | – |
| Q4 2016 | $307,000 | +2.0% | 41,494 | -38.1% | 0.00% | – |
| Q2 2016 | $301,000 | +71.0% | 67,085 | -5.2% | 0.00% | – |
| Q1 2016 | $176,000 | -44.3% | 70,753 | +80.9% | 0.00% | – |
| Q4 2015 | $316,000 | +587.0% | 39,101 | +397.7% | 0.00% | – |
| Q2 2014 | $46,000 | – | 7,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |